Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells zum Wirkstoff Certolizumab pegol (ATC-Code nach WHO: L04AB05)

The subject of this publication is the conclusion of non-exclusive discount agreements in accordance with Section 130a Paragraph 8 SGB V for medicinal products with the active ingredient certolizumab pegol (ATC code according to WHO: L04AB05). The contract is concluded within the framework of a so-called open house model, i.e. h. The conclusion of a contract is open to all interested pharmaceutical companies within the participation period, provided they meet and accept the participation requirements. This means that individual contract negotiations are not carried out and (delivery) exclusivity is not given. It should be noted that the purchase quantity is unknown because it depends on demand and the development of the number of insured people, on the prescribing behavior of doctors and the dispensing and stocking behavior of public pharmacies. Minimum purchase quantities are therefore not guaranteed. Interested pharmaceutical companies can download the participation documents via the project room of the German Procurement Portal (DTVP). To do this, you must first submit an application for access to the project room. After activation by the client, the participation documents can then be accessed. Absolute confidentiality must be maintained regarding the content of the participation documents - in particular the content of the discount agreement and the discounts mentioned there. Full or partial disclosure or access to the contents of the participation documents to or for third parties requires the prior written consent of the client. If you decide not to participate, all documents must be destroyed immediately in accordance with data protection regulations. The documents to be submitted can be found in the “cover letter” and “explanations of the contractual conditions” documents stored in the project room. Communication, including the transmission of participation documents, takes place electronically via the DTVP procurement portal; Details can be found in the documents mentioned above. Any information to the contrary in the order notice is due to technical reasons and is not binding. Applications for participation can be submitted for the first time until December 2nd, 2026. For all other submission deadlines, please refer to the “Submission Deadlines” appendix in the project room. If the day of the submission deadline falls on a Saturday, Sunday or a national public holiday, tr